Pharmafile Logo
Pharmafocus logo
Advanced Search

Allergan

Showing 15 posts of 142 posts found.

david_nicholson

Allergan R&D Chief named as Chairman of Exscientia’s Board of Directors

October 8, 2020
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Allergan, Exscientia, appointment

Artificial intelligence-driven drug discovery firm Exscientia has named industry veteran Dr David Nicholson, current Executive Vice President and Chief R&D …

Appointment
fdaoutsideweb

FDA rejects Allergan’s Abicipar pegol for neovascular age-related macular degeneration over benefit/risk concerns

June 29, 2020
Sales and Marketing AbbVie, Allergan, FDA, pharma

The FDA has moved to reject Allergan’s vascular endothelial growth factor (VEGF) factor A inhibitor, Abicipar pegol, as treatment for …

News
shutterstock_273326141

$63bn Allergan/AbbVie merger review could be delayed by coronavirus

March 18, 2020
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing AbbVie, Allergan, merger, pharma

The $63 billion merger of major pharma players AbbVie and Allergan could be facing hurdles on the road to regulatory …

News
allergan

Allergan’s ubrogepant doses smash primary endpoints in acute treatment of migraine

December 5, 2019
Research and Development Allergan, FDA, pharma, ubrogepant

New Phase 3 data has been released showing that both 50mg and 100mg doses of Allergan’s ubrogepant met their primary …

News
allergan

Allergan’s acute migraine therapy ubrogepant shows strength at Phase 3

November 20, 2019
Research and Development Allergan, pharma, ubrogepant

Allergan has revealed positive Phase 3 data on its oral calcitonin gene-related peptide (CGRP) receptor antagonist ubrogepant, illustrating the therapy’s …

News
4420456374_64a3d7e6aa

Top Ten most popular articles on Pharmafile.com this week

June 28, 2019
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing AbbVie, Allergan, Bristol-Myers Squibb, China, GSK, Novartis, Takeda, brexit

This week was diverse as always in terms of news coming out of the pharma industry, but the biggest news …

News
shutterstock_273326141

AbbVie poised to acquire Allergan for $63 billion

June 26, 2019
Research and Development, Sales and Marketing AbbVie, Allergan, acqusition, pharma

The industry has been rocked with the announcement of another pharmaceutical mega-merger, as it emerged that AbbVie had sealed an …

News
allergan

Allergan shareholders reject proposal to split roles of chairman and CEO

May 2, 2019
Research and Development Allergan, Appaloosa, CEO, board of directors, hedge fund, pharma

Allergan shareholders have rejected a proposal to immediately separate the roles of CEO and chairman, both of which are currently …

News
allergan

FDA approves first paediatric treatment for intra-abdominal and urinary tract infections in over 10 years

March 19, 2019
Manufacturing and Production, Sales and Marketing Allergan, Avycaz, FDA, pharma

Allergan has revealed that Avycaz (ceftazidime and avibactam) has been awarded an expansion of its label by the FDA to include …

News
allergan

Allergan’s depression drug rapastinel fails to outperform placebo at Phase 3

March 7, 2019
Research and Development Allergan, FDA, depression, major depressive disorder, pharma, rapastinel

As Janssen celebrated the FDA approval of the first novel therapy for depression in three decades with Spravato, Allergan released …

News
allergan

Allergan and St Regis Mohawk Tribe take patent ruling to Supreme Court

January 28, 2019
Sales and Marketing Allergan, Mohawk, Restasis, St Regis, eye drops, patents

Allergan and the St Regis Mohawk Tribe have asked the Supreme Court to defend a 2017 patent agreement which would …

News
daphne_karydas

Allergan strengthens Finance Leadership Team with two appointments

December 12, 2018
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Allergan, MIT, Regeneron, appointment, pharma

The Dublin-headquartered multinational Allergan has appointed two experienced pharma investors to its Finance Leadership Team. The biopharmaceutical firm yesterday announced …

Appointment
allergan

Allergan acquires neurotoxin specialist Bonti in $195m deal

September 17, 2018
Sales and Marketing Allergan, Bonti, Botox, Neurotoxin, acquisition, deal

The Dublin-headquartered multinational Allergan have agreed to acquire the clinical stage biotech Bonti in a deal worth more than $195 …

News
allergan

FDA refuses Allergan’s uterine bleeding therapy with a request for more data

August 22, 2018
Research and Development, Sales and Marketing Allergan, Esmya, FDA, pharma

Allergan has shared the news that the FDA has refused to award marketing authorisation to its ulipristal acetate product Esmya …

News
top_10_image

Top Ten most popular articles on Pharmafile.com this week

August 10, 2018
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing ADHD, Allergan, MHRA, UK, brexit, iraq, pharma, top 10

There was some clarity on Brexit this week as the MHRA set out a plan for the implantation period set …

News

Latest content

Novo Nordisk partners with UNICEF to prevent global childhood obesity

September 21, 2023

EC approves Menarini Group’s Orserdu for breast cancer treatment

September 21, 2023

Pharmanovia acquires CNS portfolio from Sanofi

September 20, 2023

Exscientia enters AI drug discovery collaboration with Merck KGaA

September 20, 2023

EC approves Pfizer’s Litfulo for adolescents and adults with alopecia

September 19, 2023